Henry Schein Navigates Equity Shifts, Litigation in Q2

Ticker: HSIC · Form: 10-Q · Filed: 2025-08-05T00:00:00.000Z

Sentiment: mixed

Topics: Medical Supplies, Dental Equipment, Wholesale Trade, Equity Compensation, Litigation Risk, Capital Management, Q2 Earnings

Related Tickers: HSIC

TL;DR

**HSIC is actively managing its equity and facing litigation, so watch for potential dilution and legal headwinds.**

AI Summary

HENRY SCHEIN INC (HSIC) reported its Q2 2025 results, with the period ending June 28, 2025. The company's financial statements indicate a focus on managing equity and share-based compensation. Specifically, common stock activity for the six months ended June 28, 2025, and June 29, 2024, shows ongoing share issuance and repurchases impacting total equity. Retained earnings and additional paid-in capital also saw movements during the period from December 29, 2024, to June 28, 2025, reflecting operational profitability and capital management decisions. The company continues to utilize various equity incentive plans, including employee stock options, time-based restricted stock units, and performance-based restricted stock units, which influence compensation expenses and share dilution. Noncontrolling interests also played a role in the overall equity structure. While specific revenue and net income figures are not explicitly detailed in the provided excerpt, the emphasis on equity changes suggests active capital allocation strategies and ongoing employee incentive programs. The filing also references a multi-district litigation, indicating potential legal risks that could impact future financial performance.

Why It Matters

This filing reveals HENRY SCHEIN's active management of its capital structure through share-based compensation and equity movements, which directly impacts shareholder value and potential dilution. For investors, understanding these dynamics is crucial for assessing long-term returns and the company's commitment to employee incentives. Employees benefit from these equity plans, aligning their interests with company performance. In a competitive landscape, effective capital management and a strong incentive program can help HENRY SCHEIN attract and retain talent, potentially giving it an edge over rivals in the medical and dental equipment wholesale sector. The mention of multi-district litigation also introduces a potential overhang, which could affect market sentiment and future operational flexibility.

Risk Assessment

Risk Level: medium — The risk level is medium due to the ongoing multi-district litigation referenced for the period 2023-12-31 to 2024-12-28, which could lead to significant legal costs or settlements. Additionally, the active management of various equity incentive plans, including employee stock options and restricted stock units, introduces potential share dilution if not managed effectively, impacting existing shareholder value.

Analyst Insight

Investors should closely monitor the outcomes of the multi-district litigation and its potential financial impact on HENRY SCHEIN. Additionally, analyze the company's share-based compensation trends to assess potential dilution and its effect on earnings per share in future quarters.

Key Numbers

2025-06-28 — Reporting Period End Date (The end date for the second quarter of 2025, indicating the period covered by the 10-Q filing.)
2025-08-05 — Filing Date (The date the 10-Q was filed with the SEC.)
0001000228 — Central Index Key (CIK) (Unique identifier for HENRY SCHEIN INC with the SEC.)
10-Q — Form Type (Indicates a quarterly report filing.)
93 — Public Document Count (Number of documents included in the filing.)
1995-09-07 — Date of Name Change (When the company changed its name from SCHEIN HENRY INC to HENRY SCHEIN INC.)
2023-12-31 — Litigation Start Date (Beginning of the period for actions consolidated in multi-district litigation.)
2024-12-28 — Litigation End Date (End of the period for actions consolidated in multi-district litigation.)

Key Players & Entities

HENRY SCHEIN INC (company) — filer of the 10-Q
0001000228 (regulator) — Central Index Key (CIK) for HENRY SCHEIN INC
NASDAQ (company) — stock exchange where HSIC is likely traded
135 DURYEA RD (other) — business address of HENRY SCHEIN INC
MELVILLE (other) — city of business address
NY (other) — state of business address
11747 (other) — zip code of business address
6318435500 (other) — business phone number
SCHEIN HENRY INC (company) — former name of HENRY SCHEIN INC
2025-06-28 (other) — end date of the reporting period

FAQ

What were HENRY SCHEIN INC's key equity changes in Q2 2025?

For the six months ended June 28, 2025, HENRY SCHEIN INC saw movements in common stock, retained earnings, additional paid-in capital, and accumulated other comprehensive income, reflecting ongoing capital management and operational results.

How does HENRY SCHEIN INC manage employee incentives?

HENRY SCHEIN INC utilizes various equity incentive plans, including employee stock options, time-based restricted stock units, and performance-based restricted stock units, as detailed for the period from December 29, 2024, to June 28, 2025.

What legal risks does HENRY SCHEIN INC face?

The filing references actions consolidated in multi-district litigation for the period between December 31, 2023, and December 28, 2024, indicating potential legal exposure for HENRY SCHEIN INC.

What is the impact of noncontrolling interests on HENRY SCHEIN INC's equity?

Noncontrolling interests are a component of HENRY SCHEIN INC's overall equity structure, with changes reported for the six months ended June 28, 2025, influencing total equity attributable to the company.

When was HENRY SCHEIN INC's 10-Q for Q2 2025 filed?

HENRY SCHEIN INC filed its 10-Q for the period ending June 28, 2025, on August 5, 2025, with the SEC.

What is the business address of HENRY SCHEIN INC?

The business address for HENRY SCHEIN INC is 135 Duryea Rd, Melville, NY 11747, with a business phone number of 631-843-5500.

What was HENRY SCHEIN INC's former company name?

HENRY SCHEIN INC was formerly known as SCHEIN HENRY INC, with the name change occurring on September 7, 1995.

How do restricted stock units affect HENRY SCHEIN INC's financials?

Restricted stock units, both time-based and performance-based, are part of HENRY SCHEIN INC's equity compensation plans, impacting share count and compensation expenses over their vesting periods, as seen from December 29, 2024, to June 28, 2025.

What is the significance of the CIK 0001000228 for HENRY SCHEIN INC?

The CIK 0001000228 is the Central Index Key, a unique identifier assigned by the SEC to HENRY SCHEIN INC, used for all its filings and regulatory communications.

What should investors consider regarding HENRY SCHEIN INC's share-based compensation?

Investors should consider that HENRY SCHEIN INC's use of employee stock options and restricted stock units can lead to share dilution, which may affect earnings per share, and should be factored into valuation models.

Risk Factors

Multi-District Litigation [high — legal]: The company is involved in multi-district litigation concerning actions consolidated as of December 31, 2023, and continuing through December 28, 2024. The specific nature and potential financial impact of this litigation are not detailed in the provided excerpt, but such legal proceedings can lead to significant costs, settlements, or judgments.

Industry Context

Henry Schein Inc. operates in the wholesale distribution of medical, dental, and hospital equipment and supplies (SIC 5047). This sector is characterized by a fragmented market with numerous distributors competing on price, service, and product breadth. Key industry trends include the increasing adoption of technology in healthcare delivery, consolidation among providers, and evolving regulatory landscapes impacting product sourcing and distribution.

Regulatory Implications

As a distributor of medical and dental supplies, Henry Schein is subject to various regulations concerning product safety, import/export controls, and supply chain integrity. Compliance with these regulations is critical to avoid penalties and maintain market access. The company's involvement in multi-district litigation also highlights potential regulatory or legal scrutiny that could necessitate ongoing compliance efforts and risk management.

What Investors Should Do

[object Object]
[object Object]
[object Object]

Key Dates

2025-06-28: Reporting Period End Date — Marks the end of the second quarter of 2025, for which the 10-Q filing provides financial data.
2025-08-05: Filing Date — The date the 10-Q report was officially submitted to the SEC, indicating the availability of the company's latest quarterly financial information.
1995-09-07: Date of Name Change — Indicates the historical name change from SCHEIN HENRY INC to HENRY SCHEIN INC, relevant for historical context and entity tracking.
2023-12-31: Litigation Start Date — Marks the beginning of the period for actions consolidated in the multi-district litigation, providing a timeframe for the legal proceedings.
2024-12-28: Litigation End Date — Marks the end of the period for actions consolidated in the multi-district litigation, defining the scope of the legal proceedings covered in this filing.
2024-12-29: Start of reporting period for equity changes — This date marks the beginning of the period for which changes in equity components like retained earnings, additional paid-in capital, and common stock activity are detailed.

Glossary

us-gaap:RetainedEarningsMember: The cumulative earnings of a company that have not been distributed to shareholders as dividends. (Shows the company's accumulated profitability over time, impacting total equity.)
us-gaap:AdditionalPaidInCapitalMember: The amount of money a company receives from selling stock above its par value. (Reflects capital raised from stock issuance, contributing to total equity.)
us-gaap:CommonStockMember: Represents ownership in a corporation, typically with voting rights. (Activity in common stock (issuance/repurchase) directly affects the equity structure.)
us-gaap:EmployeeStockOptionMember: A right granted to employees to purchase company stock at a predetermined price within a specified period. (Impacts compensation expenses and potential share dilution.)
hsic:TimeBasedRestrictedStockRestrictedUnitsMember: Awards of company stock or units that vest over a period of time, contingent on continued employment. (A form of employee compensation that affects share count and equity.)
hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember: Awards of company stock or units that vest upon the achievement of specific performance targets. (Another form of employee compensation tied to company performance, influencing equity.)
us-gaap:NoncontrollingInterestMember: The portion of equity in a subsidiary that is not attributable to the parent company. (Represents ownership by external parties in consolidated entities, affecting the parent's total equity.)
hsic:ActionsConsolidatedInTheMultiDistrictLitigationMember: Legal cases that have been grouped together in a single federal court for pretrial proceedings. (Indicates the company's involvement in significant legal actions that could have financial implications.)

Year-Over-Year Comparison

The provided excerpt focuses on equity changes and litigation for the period ending June 28, 2025, and does not contain direct comparative financial metrics (like revenue or net income) against the prior year's 10-Q. However, the emphasis on equity movements, including common stock activity and incentive plans, suggests continued active capital management and employee compensation strategies. The ongoing multi-district litigation remains a key risk factor, with its timeframe now extended to December 28, 2024, indicating its continued relevance.

From the Filing

0001000228-25-000045.txt : 20250805 0001000228-25-000045.hdr.sgml : 20250805 20250805150318 ACCESSION NUMBER: 0001000228-25-000045 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20250628 FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HENRY SCHEIN INC CENTRAL INDEX KEY: 0001000228 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] ORGANIZATION NAME: 07 Trade & Services EIN: 113136595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1227 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27078 FILM NUMBER: 251184453 BUSINESS ADDRESS: STREET 1: 135 DURYEA RD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 6318435500 MAIL ADDRESS: STREET 1: 135 DURYEA RD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: SCHEIN HENRY INC DATE OF NAME CHANGE: 19950907 10-Q 1 hsic-20250628.htm HENRY SCHEIN 2Q 2025 10-Q hsic-20250628 false 0001000228 --12-27 none 480000000 0.01 0.01 1000000 33.33 0.004 Q2 NASDAQ http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember P5Y P3Y http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense P4Y P3Y P4Y P3Y P3Y P4Y P3Y P10Y P1Y 0001000228 2023-12-31 2024-06-29 0001000228 2024-12-28 0001000228 2024-12-29 2025-06-28 0001000228 2025-06-28 0001000228 us-gaap:RetainedEarningsMember 2024-12-29 2025-06-28 0001000228 2023-12-30 0001000228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-29 2025-06-28 0001000228 us-gaap:NoncontrollingInterestMember 2024-12-29 2025-06-28 0001000228 us-gaap:AdditionalPaidInCapitalMember 2024-12-29 2025-06-28 0001000228 us-gaap:CommonStockMember 2024-12-29 2025-06-28 0001000228 us-gaap:CommonStockMember 2025-03-30 2025-06-28 0001000228 us-gaap:EmployeeStockOptionMember 2023-12-31 2024-06-29 0001000228 us-gaap:EquityMethodInvesteeMember 2023-12-31 2024-06-29 0001000228 2025-03-30 2025-06-28 0001000228 us-gaap:RetainedEarningsMember 2025-03-30 2025-06-28 0001000228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-30 2025-06-28 0001000228 us-gaap:NoncontrollingInterestMember 2025-03-30 2025-06-28 0001000228 us-gaap:AdditionalPaidInCapitalMember 2025-03-30 2025-06-28 0001000228 hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember 2024-12-29 2025-06-28 0001000228 hsic:NonEmployeeDirectorStockIncentivePlanMember hsic:TimeBasedRestrictedStockRestrictedUnitsMember 2024-12-29 2025-06-28 0001000228 us-gaap:EmployeeStockOptionMember 2024-12-29 2025-06-28 0001000228 hsic:TimeBasedRestrictedStockRestrictedUnitsMember 2024-12-29 2025-06-28 0001000228 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:AssetPledgedAsCollateralMember 2024-12-28 0001000228 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember us-gaap:RecourseMember 2024-12-28 0001000228 us-gaap:EquityMethodInvesteeMember 2024-12-29 2025-06-28 0001000228 2024-03-31 2024-06-29 0001000228 us-gaap:EquityMethodInvesteeMember 2024-03-31 2024-06-29 0001000228 us-gaap:OtherNoncurrentLiabilitiesMember 2025-06-28 0001000228 us-gaap:OtherNoncurrentLiabilitiesMember 2024-12-28 0001000228 hsic:TimeBasedRestrictedStockRestrictedUnitsMember 2024-12-28 0001000228 hsic:TimeBasedRestrictedStockRestrictedUnitsMember 2025-06-28 0001000228 hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember 2024-12-28 0001000228 hsic:PerformanceBasedRestrictedStockRestrictedUnitsMember 2025-06-28 0001000228 us-gaap:EmployeeStockOptionMember 2024-12-29 2025-06-28 0001000228 us-gaap:EmployeeStockOptionMember 2024-03-31 2024-06-29 0001000228 us-gaap:RestrictedStockUnitsRSUMember 2024-12-29 2025-06-28 0001000228 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 2024-06-29 0001000228 hsic:ActionsConsolidatedInTheMultiDistrictLitigationMember 2023-12-31 2024-12-28 0001000228 us-gaap